The use of nonhuman primate models in HIV vaccine development

被引：80

作者：

Morgan, Cecilia ^{[1
]}

Marthas, Marta ^{[2
]}

Miller, Christopher ^{[3
]}

Duerr, Ann ^{[1
]}

Cheng-Mayer, Cecilia ^{[4
]}

Desrosiers, Ronald ^{[5
]}

Flores, Jorge ^{[6
]}

Haigwood, Nancy ^{[7
]}

Hu, Shiu-Lok ^{[8
]}

Johnson, R. Paul

Lifson, Jeffrey ^{[9
]}

Montefiori, David ^{[10
]}

Moore, John ^{[11
]}

Robert-Guroff, Marjorie ^{[12
]}

Robinson, Harriet ^{[13
]}

Self, Steven ^{[14
]}

Corey, Lawrence ^{[1
]}

机构：

[1] Fred Hutchinson Canc Res Ctr, HIV Vaccine Trials Network, Seattle, WA 98104 USA

[2] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA

[3] Univ Calif Davis, Calif Natl Primate Res Ctr, Dept Pathol Microbiol & Immunol, Sch Vet Med, Davis, CA 95616 USA

[4] Aaron Diamond AIDS Res Ctr, New York, NY USA

[5] Harvard Univ, Sch Med, New England Primate Res Ctr, Dept Microbiol & Mol Genet, Southborough, MA 01772 USA

[6] NIAID, Div Aids, Bethesda, MD 20892 USA

[7] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA

[8] Univ Washington, Washington Natl Primate Res Ctr, Dept Pharmaceut & Microbiol, Seattle, WA 98195 USA

[9] NCI, AIDS Vaccine Program, SAIC Frederick Inc, Frederick, MD USA

[10] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA

[11] Cornell Univ, Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA

[12] NCI, Sect Immune Biol Retroviral Infect, Bethesda, MD 20892 USA

[13] Emory Vaccine Ctr, Atlanta, GA USA

[14] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA

来源：

PLOS MEDICINE | 2008年 / 5卷 / 08期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1371/journal.pmed.0050173

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1200 / 1204

页数：5

共 15 条

[1] Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with DNA and recombinant adenoviral vaccine vectors expressing Gag
Casimiro, DR
Wang, FB
Schleif, WA
Liang, XP
Zhang, ZQ
Tobery, TW
Davies, ME
McDermott, AB
O'Connor, DH
Fridman, A
Bagchi, A
Tussey, LG
Bett, AJ
Finnefrock, AC
Fu, TM
Tang, AM
Wilson, KA
Chen, MC
Perry, HC
Heidecker, GJ
Freed, DC
Carella, A
Punt, KS
Sykes, KJ
Huang, LY
Ausensi, VI
Bachinsky, M
Sadasivan-Nair, U
Watkins, DI
Emini, EA
Shiver, JW
[J]. JOURNAL OF VIROLOGY, 2005, 79 (24) : 15547 - 15555
[2] Prospects for an AIDS vaccine
Desrosiers, RC
[J]. NATURE MEDICINE, 2004, 10 (03) : 221 - 223
[3] AIDS vaccine models: Challenging challenge viruses
Feinberg, MB
Moore, JP
[J]. NATURE MEDICINE, 2002, 8 (03) : 207 - 210
[4] Haigwood NL, 2004, AIDS REV, V6, P187
[5] Hu Shiu-Lok, 2005, Current Drug Targets - Infectious Disorders, V5, P193, DOI 10.2174/1568005054201508
[6] Johnson R Paul, 2006, Top HIV Med, V14, P8
[7] HIV vaccine design: insights from live attenuated SIV vaccines
Koff, WC
Johnson, PR
Watkins, DI
Burton, DR
Lifson, JD
Hasenkrug, KJ
McDermott, AB
Schultz, A
Zamb, TJ
Boyle, R
Desrosiers, RC
[J]. NATURE IMMUNOLOGY, 2006, 7 (01) : 19 - 23
[8] Progress and obstacles in the development of an AIDS vaccine
Letvin, Norman L.
[J]. NATURE REVIEWS IMMUNOLOGY, 2006, 6 (12) : 930 - 939
[9] AIDS vaccines - One step forwards, one step back
Lifson, JD
Martin, MA
[J]. NATURE, 2002, 415 (6869) : 272 - 273
[10] Malkevitch Nina V, 2004, Expert Rev Vaccines, V3, pS105, DOI 10.1586/14760584.3.4.S105

← 1 2 →